{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T14:27:09Z","timestamp":1773066429898,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.reprotox.2013.12.007","type":"journal-article","created":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T05:46:46Z","timestamp":1388728006000},"page":"14-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Congenital bladder exstrophy associated with Duogynon hormonal pregnancy tests\u2014Signal for teratogenicity or consumer report bias?"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7025-5143","authenticated-orcid":false,"given":"Gregor","family":"T\u00fcmmler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke","family":"Ri\u00dfmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1416-5784","authenticated-orcid":false,"given":"Reinhard","family":"Meister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christof","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5110","key":"10.1016\/j.reprotox.2013.12.007_bib0005","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/216083a0","article-title":"Hormonal pregnancy tests and congenital malformation","volume":"216","author":"Gal","year":"1967","journal-title":"Nature"},{"issue":"6068","key":"10.1016\/j.reprotox.2013.12.007_bib0010","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1136\/bmj.1.6068.1058","article-title":"Congenital heart disease and prenatal exposure to exogenous sex hormones","volume":"1","author":"Janerich","year":"1977","journal-title":"Br Med J"},{"issue":"5","key":"10.1016\/j.reprotox.2013.12.007_bib0015","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/0002-9378(86)90352-2","article-title":"Congenital limb reduction deformities and use of oral contraceptives","volume":"155","author":"Kricker","year":"1986","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.reprotox.2013.12.007_bib0020","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archpedi.159.10.957","article-title":"Maternal progestin intake and risk of hypospadias","volume":"159","author":"Carmichael","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"7823","key":"10.1016\/j.reprotox.2013.12.007_bib0025","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0140-6736(73)93154-1","article-title":"Hormonal pregnancy tests and congenital malformations","volume":"2","author":"Oakley","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.reprotox.2013.12.007_bib0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/tera.1420270109","article-title":"Prospective study of suspected associations between certain drugs administered during early pregnancy and congenital malformations","volume":"27","author":"Michaelis","year":"1983","journal-title":"Teratology"},{"issue":"3","key":"10.1016\/j.reprotox.2013.12.007_bib0035","first-page":"552","article-title":"Oral contraception and congenital malformations in offspring: a review and metaanalysis of the prospective studies","volume":"76","author":"Bracken","year":"1990","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.reprotox.2013.12.007_bib0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/bdra.10012","article-title":"Guidelines for case classification for the National Birth Defects Prevention Study","volume":"67","author":"Rasmussen","year":"2003","journal-title":"Birth Defects Res A: Clin Mol Teratol"},{"key":"10.1016\/j.reprotox.2013.12.007_bib0045","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/bdra.20780","article-title":"Paper 1: The EUROCAT network \u2013 organization and processes","volume":"91","author":"Boyd","year":"2011","journal-title":"Birth Defects Res A: Clin Mol Teratol"},{"issue":"1","key":"10.1016\/j.reprotox.2013.12.007_bib0050","first-page":"51","article-title":"Paper 6: EUROCAT member registries: organization and activities","volume":"91","author":"Greenlees","year":"2011","journal-title":"Birth Defects Res A: Clin Mol Teratol"},{"key":"10.1016\/j.reprotox.2013.12.007_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpurol.2013.05.001","article-title":"New insights into the pathogenesis of bladder exstrophy\u2013epispadias complex","author":"Mahfuz","year":"2013","journal-title":"J Pediatr Urol"},{"issue":"5","key":"10.1016\/j.reprotox.2013.12.007_bib0060","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1097\/01.ju.0000154821.21521.9b","article-title":"Contemporary epidemiology of bladder exstrophy in the United States","volume":"173","author":"Nelson","year":"2005","journal-title":"J Urol"},{"issue":"9","key":"10.1016\/j.reprotox.2013.12.007_bib0065","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00120-005-0863-z","article-title":"Genetic and molecular biological aspects of the bladder exstrophy\u2013epispadias complex (BEEC)","volume":"44","author":"Ludwig","year":"2005","journal-title":"Urologe A"},{"issue":"2","key":"10.1016\/j.reprotox.2013.12.007_bib0070","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/tera.1420360210","article-title":"Epidemiology of bladder exstrophy and epispadias: a communication from the International Clearinghouse for Birth Defects Monitoring Systems","volume":"36","author":"International Clearinghouse for Birth Defects Monitoring Systems","year":"1987","journal-title":"Teratology"},{"issue":"4","key":"10.1016\/j.reprotox.2013.12.007_bib0075","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/ajmg.c.30316","article-title":"Bladder exstrophy: an epidemiologic study from the International Clearinghouse for Birth Defects Surveillance and Research, and an overview of the literature","volume":"157C","author":"Siffel","year":"2011","journal-title":"Am J Med Genet C: Semin Med Genet"},{"issue":"1","key":"10.1016\/j.reprotox.2013.12.007_bib0080","first-page":"31","article-title":"Paper 4: EUROCAT statistical monitoring: identification and investigation of ten year trends of congenital anomalies in Europe","volume":"91","author":"Loane","year":"2011","journal-title":"Birth Defects Res A: Clin Mol Teratol"},{"key":"10.1016\/j.reprotox.2013.12.007_bib0085","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.reprotox.2008.05.064","article-title":"Using observational cohort data for studying drug effects on pregnancy outcome \u2013 methodological considerations","volume":"26","author":"Schaefer","year":"2008","journal-title":"Reprod Toxicol"},{"issue":"2","key":"10.1016\/j.reprotox.2013.12.007_bib0090","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/oxfordjournals.aje.a115145","article-title":"Reporting accuracy among mothers of malformed and nonmalformed infants","volume":"129","author":"Werler","year":"1989","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.reprotox.2013.12.007_bib0095","series-title":"Drugs during pregnancy and lactation","author":"Schaefer","year":"2007"},{"issue":"2","key":"10.1016\/j.reprotox.2013.12.007_bib0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1056\/NEJM197901113000206","article-title":"Maternal progestins as a possible cause of hypospadias","volume":"300","author":"Aarskog","year":"1979","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.reprotox.2013.12.007_bib0105","first-page":"330","article-title":"Urinary tract changes associated with exposure in utero to diethylstilbestrol","volume":"56","author":"Kaufman","year":"1980","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.reprotox.2013.12.007_bib0110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/tera.1420380107","article-title":"Case control study of hypospadias, based on registry information","volume":"38","author":"K\u00e4ll\u00e9n","year":"1988","journal-title":"Teratology"},{"issue":"2","key":"10.1016\/j.reprotox.2013.12.007_bib0115","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0010-7824(91)90117-X","article-title":"Oral contraceptives in the etiology of isolated hypospadias","volume":"44","author":"K\u00e4ll\u00e9n","year":"1991","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.reprotox.2013.12.007_bib0120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/tera.1420510105","article-title":"Oral contraceptive use after conception in relation to the risk of congenital urinary tract anomalies","volume":"51","author":"Li","year":"1995","journal-title":"Teratology"},{"issue":"1","key":"10.1016\/j.reprotox.2013.12.007_bib0125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0029-7844(94)00341-A","article-title":"Fetal genital effects of first trimester sex hormone exposure: a meta-analysis","volume":"85","author":"Raman-Wilms","year":"1995","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.reprotox.2013.12.007_bib0130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/tera.1420350115","article-title":"Embryotoxicity of sex steroidal hormone combinations in nonhuman primates. I. Norethisterone acetate+ethinylestradiol and progesterone+estradiol benzoate (Macaca mulatta, Macaca fascicularis, and Papio cynocephalus)","volume":"35","author":"Hendrickx","year":"1987","journal-title":"Teratology"},{"issue":"2","key":"10.1016\/j.reprotox.2013.12.007_bib0135","first-page":"70","article-title":"Hypospadias, androgen biosynthesis, and synthetic progestogens during pregnancy","volume":"27","author":"Briggs","year":"1982","journal-title":"Int J Fertil"},{"issue":"2","key":"10.1016\/j.reprotox.2013.12.007_bib0140","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/toxsci\/kfg180","article-title":"In utero through lactational exposure to ethinyl estradiol induces cleft phallus and delayed ovarian dysfunction in the offspring","volume":"75","author":"Sawaki","year":"2003","journal-title":"Toxicol Sci"},{"issue":"24","key":"10.1016\/j.reprotox.2013.12.007_bib0145","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/240241a0","article-title":"Risks and benefits of the use of hormonal pregnancy test tablets","volume":"240","author":"Gal","year":"1972","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.reprotox.2013.12.007_bib0150","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0002-9378(15)33279-8","article-title":"Are female sex hormones teratogenic?","volume":"141","author":"Wilson","year":"1981","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.reprotox.2013.12.007_bib0155","first-page":"1","article-title":"Do contraceptive methods pose fetal risks?","volume":"3","author":"Simpson","year":"1985","journal-title":"Res Front Fertil Regul"},{"issue":"2","key":"10.1016\/j.reprotox.2013.12.007_bib0160","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0890-6238(98)00072-0","article-title":"Pregnancy outcome after exposure to misoprostol in Brazil: a prospective, controlled study","volume":"13","author":"Sch\u00fcler","year":"1999","journal-title":"Reprod Toxicol"},{"issue":"1","key":"10.1016\/j.reprotox.2013.12.007_bib0165","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ajmg.a.20503","article-title":"Methotrexate\/misoprostol embryopathy: report of four cases resulting from failed medical abortion","volume":"123A","author":"Adam","year":"2003","journal-title":"Am J Med Genet A"},{"issue":"5 Pt 2","key":"10.1016\/j.reprotox.2013.12.007_bib0170","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/01.AOG.0000154002.26761.41","article-title":"Anomalies associated with failed methotrexate and misoprostol termination","volume":"105","author":"Yedlinsky","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.reprotox.2013.12.007_bib0175","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1345\/aph.1K550","article-title":"M\u00f6bius syndrome in a neonate after mifepristone and misoprostol elective abortion failure","volume":"42","author":"Bos-Thompson","year":"2008","journal-title":"Ann Pharmacother"},{"issue":"5","key":"10.1016\/j.reprotox.2013.12.007_bib0180","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/1471-0528.12147","article-title":"Continuation of pregnancy after first-trimester exposure to mifepristone: an observational prospective study","volume":"120","author":"Bernard","year":"2013","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.reprotox.2013.12.007_bib0185","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/bdra.10021","article-title":"Bendectin and birth defects: hopefully, the final chapter","volume":"67","author":"Brent","year":"2003","journal-title":"Birth Defects Res A: Clin Mol Teratol"}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623813003882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623813003882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:36:33Z","timestamp":1760189793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623813003882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":37,"alternative-id":["S0890623813003882"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2013.12.007","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Congenital bladder exstrophy associated with Duogynon hormonal pregnancy tests\u2014Signal for teratogenicity or consumer report bias?","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2013.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}